The New York-based startup is focused on using AI to accurately predict not only if a patient has cancer, but also what their ...
Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results